NL-OMON47554
Recruiting
Not Applicable
Spinal cord stimulation for treating neuropathic pain after chemotherapy / radiotherapy; a pilot study - SCS for post-cancer neuropathy, SCS002p
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- neuropathic pain caused by chemotherapy / radiotherapy
- Sponsor
- Medisch Spectrum Twente
- Enrollment
- 11
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Peripheral neuropathic pain in lower extremities that exists for more than 6
- •months and is due to chemotherapy / radiotherapy.
- •\- Patient cannot be treated further otherwise according to patients\* medical
- •specialist.
- •\- The pain\-sensation on a visual analogue scale is 5 or more.
Exclusion Criteria
- •\- Psychological problems that requires treatment.
- •\- Insufficient cooperation by patient (motivation, insight or communication).
- •\- Coagulation irregularities/ Anti\-coagulants.
- •\- Life expectancy less than 1 year.
- •\- Local infection at the site of the incision
- •\- Implanted pacemaker, ICD or other neuromodulation system
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Spinal cord stimulation for treating neuropathic pain after chemotherapy / radiotherapy; a pilot study.neuropathic post-cancer pain,NL-OMON25222Medisch Spectrum Twente11
Recruiting
Not Applicable
Spinal Cord Stimulation for intractable chronic lower abdominal neuropathic pain caused by endometriosisNL-OMON50815Academisch Medisch Centrum15
Not yet recruiting
Not Applicable
Spinal Cord stimulation for Intractable MONOneuropathymononeuropathy10034606NL-OMON56537Erasmus MC, Universitair Medisch Centrum Rotterdam15
Recruiting
Not Applicable
Percutaneous nerve stimulation in severe neuropathic pain patients due to spinal cord injury: a feasibility studyNL-OMON34598Reade, voormalig revalidatiecentrum amsterdam RCA15
Recruiting
Not Applicable
Onderzoek naar ruggenmergstimulatie voor de behandeling van diabetische neuropathische pijn, een evaluatie studieNL-OMON29505Medisch Spectrum Twente,<br>Enschede, the Netherlands20